ORAMED PHARMACEUTICALS INC.·4

Jan 5, 5:20 PM ET

Shapiro Benjamin 4

4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 5, 2026

Insider Transaction Report

Form 4
Period: 2025-12-31
Transactions
  • Award

    Common Stock

    2025-12-31+30,000119,720 total
  • Award

    Common Stock

    2025-12-31+3,500123,220 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,900,000
Footnotes (3)
  • [F1]Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.
  • [F2]Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.
  • [F3]These shares of Common Stock are held by a trust of which the reporting person is a trustee and beneficiary.

Documents

1 file
  • 4
    ownership.xmlPrimary